Board certified in internal medicine, and a qualified sociologist, Dr Wartman is the President of the Association of Academic Health Centers (AAHC), which represents more than 90 academic health centres across the United States. He is internationally recognised for his work, which includes tackling the issue of aligning clinical, research and education programmes within institutions to improve outcomes and ultimately patient benefit.
On Tuesday 06 May 2014, Dr Wartman toured Manchester’s ‘Knowledge Corridor’, meeting Chief Executive of Manchester City Council Sir Howard Bernstein, MAHSC Director Ian Jacobs and Chief Executive of Manchester Science Park Rowena Burns. He also spoke with Mike Deegan and Bob Pearson, respectively Central Manchester University Hospitals NHS Foundation Trust’s Chief Executive and Medical Director; and President of The University of Manchester Professor Dame Nancy Rothwell.
Dr Wartman also took time to discuss several areas of MAHSC’s work with those leading the partnership’s major programmes, including Professor Aidan Halligan, who heads up strategy for improving poor health outcomes in deprived areas; Professor Iain Buchan, a specialist in Health Informatics; Director of Business Development Linda Magee; and Director of MIMIT Jackie Oldham.
Collaborations between leading academic and health centres are prized internationally for their enormous impact on health within the population. They are not only vital providers of patient care, but they are also essential to boosting the expertise of tomorrow’s healthcare providers and pioneers through their comprehensive academic programmes.
It was on this topic that Dr Wartman led a timely and engaging lecture entitled Mission Disruption: The Transformation of Education, Research and Patient Care. He spoke widely on the revolutionary impact of AHSCs, but also highlighted the challenges that many Centres face and the solutions that have been found.
Peter Noble, MAHSC Chief Operating Officer, said: “Dr Wartman’s presentation struck at the heart of both the successes Manchester has achieved and the challenges we face as we strive to translate our innovative research and education into healthcare in order to deliver major benefits for patients and populations.
“His visit stimulated rich discussion on our future priorities and his visit has ignited much interest in Manchester being the UK Office for the AAHC. This is a matter we will be exploring with Dr Wartman over the coming weeks.”